Anavex Life Sciences Faces $43M Annual Loss
Anavex Life Sciences reports Q4 loss of $11.6M and $43M annual loss, with shares down 7% this year. Investors remain cautious about future prospects.
Anavex Life Sciences reported a Q4 loss of $11.6 million, or 14 cents per share, and an annual loss of $43 million, or 52 cents per share. Shares have fallen over 7% this year.